Bionano Genomics Q2 2024 GAAP EPS $(0.24) Beats $(0.42) Estimate, Sales $7.771M Miss $8.003M Estimate
Bionano Genomics Q2 2024 GAAP EPS $(0.24) Beats $(0.42) Estimate, Sales $7.771M Miss $8.003M Estimate
bionano genomics 2024年Q2 GAAP每股收益爲$(0.24)，超出$(0.42)的預期，並且銷售額爲777.1萬美元，低於預期的800.3萬美元。
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.42) by 42.86 percent. This is a 80.65 percent increase over losses of $(1.24) per share from the same period last year. The company reported quarterly sales of $7.771 million which missed the analyst consensus estimate of $8.003 million by 2.90 percent. This is a 10.29 percent decrease over sales of $8.662 million the same period last year.
bionano genomics（納斯達克：BNGO）報告了每股虧損0.24美元，超出了分析師預期的0.42美元的42.86％。這比去年同期每股虧損1.24美元增加了80.65％。該公司報告的季度銷售額爲777.1萬美元，較分析師預計的800.3萬美元低2.90％。這是去年同期銷售額的10.29％降低。
資訊熱榜
更新時間